• Issue

    Liver International: Volume 44, Issue 6

    i, 1269-1477
    June 2024
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

COVER IMAGE

Free Access

Cover Image

Yuan Guan,  Gary Peltz, 
  • Page: i
  • First Published: 22 May 2024
Cover Image Volume 44 Issue 6, 2024

The cover image is based on the Mini Review Hepatic organoids move from adolescence to maturity by Yuan Guan et al., https://doi.org/10.1111/liv.15893

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 1269-1272
  • First Published: 22 May 2024

EDITORIALS

Free Access

The ‘BCLC upon progression’ classification: After repeated validation, it is time to incorporate it in trial design

Manuel de la Torre-Aláez,  Maria Reig, 
  • Pages: 1273-1275
  • First Published: 22 May 2024
Free Access

Considering nutritional status to improve outcomes of patients treated by atezolizumab–bevacizumab for advanced hepatocellular carcinoma

Manon Allaire,  Matias A. Avila, 
  • Pages: 1276-1277
  • First Published: 22 May 2024
Free Access

Against multidisciplinarity: More is not necessarily better

Agostino Colli,  Daniele Prati, 
  • Pages: 1278-1280
  • First Published: 22 May 2024
Free Access

Locoregional therapies for cholangiocarcinoma: Where they stand?

Ángeles García-Criado,  Alexandre Soler,  Ezequiel Mauro,  Alejandro Forner, 
  • Pages: 1281-1282
  • First Published: 22 May 2024
Free Access

First-line treatment of BCLC 0-A HCC transplantable patients: The era of minimally invasive techniques

Christian Hobeika, 
  • Pages: 1283-1285
  • First Published: 22 May 2024

BRIEF REPORT

Open Access

Artificial replication cohort: Leveraging AI-fabricated data for genetic studies

Wiktor Smyk,  Krystian Adrych,  Marcin Krawczyk, 
  • Pages: 1286-1289
  • First Published: 01 March 2024

MINI REVIEW

Open Access

Hepatic organoids move from adolescence to maturity

Yuan Guan,  Gary Peltz, 
  • Pages: 1290-1297
  • First Published: 07 March 2024

REVIEW

Open Access

Proactive case finding of alcohol-related liver disease in high-risk populations: A systematic review

Ann J. Archer,  Jennifer Phillips,  Mohsan Subhani,  Zoe Ward,  Fiona H. Gordon,  Matthew Hickman,  Ashwin D. Dhanda,  Kushala W. M. Abeysekera, 
  • Pages: 1298-1308
  • First Published: 08 March 2024

ORIGINAL ARTICLES

Open Access

Prevalence of hepatic steatosis and fibrosis in Turner syndrome: A prospective case–control study

Patrick Twohig,  Ling Li,  David Danford,  Mary Craft,  Anji T. Yetman, 
  • Pages: 1309-1315
  • First Published: 23 February 2024

Disparities among ethnic groups in mortality and outcomes among adults with MASLD: A multicenter study

Majd B. Aboona,  Claire Faulkner,  Pooja Rangan,  Cheng Han Ng,  Daniel Q. Huang,  Mark Muthiah,  Moises I. Nevah Rubin,  Ma Ai Thanda Han,  Michael B. Fallon,  Donghee Kim,  Vincent L. Chen,  Karn Wijarnpreecha, 
  • Pages: 1316-1328
  • First Published: 26 February 2024

Global burden of acute hepatitis E between 1990 and 2019 and projections until 2030

Guoqing Ouyang,  Guangdong Pan,  Qiuyun Li,  Shuang Li,  Tao Liu,  Xiaolei Yi,  Zhipeng Liu, 
  • Pages: 1329-1342
  • First Published: 01 March 2024

Progression pattern and post-progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma

Satoshi Kobayashi,  Taito Fukushima,  Makoto Ueno,  Makoto Chuma,  Kazushi Numata,  Kota Tsuruya,  Yoshitaka Arase,  Shunji Hirose,  Tatehiro Kagawa,  Nobuhiro Hattori,  Tsunamasa Watanabe,  Kotaro Matsunaga,  Haruki Uojima,  Hisashi Hidaka,  Chika Kusano,  Manabu Morimoto,  Shin Maeda, 
  • Pages: 1343-1350
  • First Published: 04 March 2024

Multitask deep learning for prediction of microvascular invasion and recurrence-free survival in hepatocellular carcinoma based on MRI images

Fang Wang,  Gan Zhan,  Qing-qing Chen,  Hou-yun Xu,  Dan Cao,  Yuan-yuan Zhang,  Yin-hao Li,  Chu-jie Zhang,  Yao Jin,  Wen-bin Ji,  Jian-bing Ma,  Yun-jun Yang,  Wei Zhou,  Zhi-yi Peng,  Xiao Liang,  Li-ping Deng,  Lan-fen Lin,  Yen-wei Chen,  Hong-jie Hu, 
  • Pages: 1351-1362
  • First Published: 04 March 2024

Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma

Clémentine Alitti,  Agnès Rode,  Hervé Trillaud,  Philippe Merle,  Jean-Frédéric Blanc,  Lorraine Blaise,  Alix Demory,  Gisele Nkontchou,  Véronique Grando,  Marianne Ziol,  Pierre Nahon,  Nathalie Ganne-Carrié,  Arthur Petit,  Olivier Seror,  Olivier Sutter,  Jean-Charles Nault, 
  • Pages: 1363-1372
  • First Published: 04 March 2024

Health information in short videos about metabolic dysfunction-associated steatotic liver disease: Analysing quality and reliability

Ruihao Ding,  Qingzhou Kong,  Longfei Sun,  Xuyan Liu,  Leiqi Xu,  Yueyue Li,  Xiuli Zuo,  Yanqing Li, 
  • Pages: 1373-1382
  • First Published: 05 March 2024

Open Access

Impact of new direct-acting antiviral therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection

Farinaz Forouzannia,  Abdullah Hamadeh,  Ana Maria Passos-Castilho,  Aysegul Erman,  Amanda Yu,  Zeny Feng,  Naveed Z. Janjua,  Beate Sander,  Christina Greenaway,  William W. L. Wong, 
  • Pages: 1383-1395
  • First Published: 06 March 2024
Open Access

Recipient age influences survival after liver transplant: Results of the French national cohort 2007–2017

Lea Lerosey,  Elea Ksiasek,  Michal Abrahamowicz,  Corinne Antoine,  Sébastien Dharancy,  Jérôme Dumortier,  Alexandre Doussot,  Vincent Di Martino,  Pauline Houssel-Debry,  Filomena Conti,  Claire Francoz,  Georges-Philippe Pageaux,  Ephrem Salame,  François Faitot,  Audrey Coilly,  Jean Hardwigsen,  Thomas Decaens,  Faiza Chermak,  Fabrice Muscari,  Rodolphe Anty,  Christophe Duvoux,  Armand Abergel,  Anne Minello,  Thomas Mouillot,  Christine Binquet,  Marianne Latournerie, 
  • Pages: 1396-1408
  • First Published: 07 March 2024

Drug-induced liver injury (DILI) ascribed to non-steroidal anti-inflammatory drugs (NSAIDs) in the USA—Update with genetic correlations

Herbert L. Bonkovsky,  Marwan Ghabril,  Paola Nicoletti,  Andrew Dellinger,  Robert J. Fontana,  Huiman Barnhart,  Jiezhun Gu,  Ann K. Daly,  Guruprasad P. Aithal,  Elizabeth J. Phillips,  David E. Kleiner,  the US DILIN Investigators , 
  • Pages: 1409-1421
  • First Published: 07 March 2024

Tenofovir alafenamide or tenofovir disoproxil fumarate in pregnancy to prevent HBV transmission: Maternal ALT trajectory and infant outcomes

Huey-Ling Chen,  Chien-Nan Lee,  Chin-Hao Chang,  Ming-Wei Lai,  Ming-Chieh Tsai,  Shu-Chi Mu,  Chun-Jen Liu,  Jin-Chung Shih,  Wan-Hsin Wen,  Rui-Ting Hu,  Chun-Pin Huang,  Kuang-Chun Hu,  Chie-Pein Chen,  Chyi-Long Lee,  Rong-Nan Chien,  Kai-Chi Chang,  Hong-Yuan Hsu,  Chien-Chang Lee,  Yen-Hsuan Ni,  Mei-Hwei Chang, 
  • Pages: 1422-1434
  • First Published: 08 March 2024
Open Access

An optimized short-term steroid therapy for chronic drug-induced liver injury: A prospective randomized clinical trial

Ang Huang,  Yun Zhu,  Shuhong Liu,  Ying Sun,  Zherui Liu,  Qing-sheng Liang,  Jun Zhao,  Bin-xia Chang,  Jing-feng Bi,  Jiang-tao Liu,  Xing-ran Zhai,  Huan Xie,  Ning Li,  Hui Tian,  Lin Han,  Yingjie Zhuang,  Hongbin Ma,  Guang-ju Teng,  Wei Zhang,  Guruprasad P. Aithal,  Dong Ji,  Jingmin Zhao,  Zhengsheng Zou, 
  • Pages: 1435-1447
  • First Published: 14 March 2024

The associations between fibrosis changes and liver-related events in patients with metabolic dysfunction-associated steatotic liver disease

Hye Won Lee,  Kun Hee Kim,  Sang Hoon Ahn,  Han Chu Lee,  Jonggi Choi, 
  • Pages: 1448-1455
  • First Published: 15 March 2024
Open Access

Predictive factors for transition to conversion therapy in hepatocellular carcinoma using atezolizumab plus bevacizumab

Tatsuya Kikuchi,  Yasuto Takeuchi,  Kazuhiro Nouso,  Kazuya Kariyama,  Kenji Kuwaki,  Junichi Toshimori,  Shota Iwado,  Akio Moriya,  Hiroaki Hagihara,  Hiroyuki Takabatake,  Toshifumi Tada,  Tetsuya Yasunaka,  Masahiro Sakata,  Masahiko Sue,  Nozomi Miyake,  Takuya Adachi,  Nozomu Wada,  Hideki Onishi,  Hidenori Shiraha,  Akinobu Takaki,  Motoyuki Otsuka, 
  • Pages: 1456-1463
  • First Published: 15 March 2024

Upfront multi-bipolar radiofrequency ablation for HCC in transplant-eligible cirrhotic patients with salvage transplantation in case of recurrence

Carina Boros,  Olivier Sutter,  François Cauchy,  Nathalie Ganne-Carrié,  Pierre Nahon,  Gisele N'kontchou,  Marianne Ziol,  Véronique Grando,  Alix Demory,  Lorraine Blaise,  Fédérica Dondero,  François Durand,  Olivier Soubrane,  Mickael Lesurtel,  Alexis Laurent,  Oliver Seror,  Jean Charles Nault, 
  • Pages: 1464-1473
  • First Published: 06 April 2024

RESEARCH LETTER

Open Access

Combination of heterozygous APOB gene mutation with PNPLA3 and TM6SF2 variants promotes steatotic liver disease, cirrhosis and HCC development

Yasmina Chouik,  Mathilde Di Filippo,  Sylvie Radenne,  Jérôme Dumortier,  Philippe Moulin,  Massimo Levrero, 
  • Pages: 1474-1477
  • First Published: 29 February 2024